Aigen Investment Management »

Autolus Therapeutics Plc spon ads shares owned by Aigen Investment Management

Quarter-by-quarter ownership of Autolus Therapeutics Plc spon ads (AUTL) shares owned by Aigen Investment Management from 13F filings

Historical chart of Aigen Investment Management investment in Autolus Therapeutics Plc spon ads

Tip: Access up to 7 years of quarterly data

All positions including Autolus Therapeutics Plc spon ads held by Aigen Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Autolus Therapeutics Plc spon ads by Aigen Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $107k 66k 1.63

More positions owned by Aigen Investment Management

Meta Platforms Cl A (META)
Honeywell International (HON)
Boston Scientific Corporation (BSX)
Nrg Energy Com New (NRG)
Microsoft Corporation (MSFT)
Charles Schwab Corporation (SCHW)
Keurig Dr Pepper (KDP)
Citigroup Com New (C)
O'reilly Automotive (ORLY)
Norfolk Southern (NSC)
Chubb (CB)
NVIDIA Corporation (NVDA)
Fiserv (FI)
Hf Sinclair Corp (DINO)
Metropcs Communications (TMUS)

View all positions for Aigen Investment Management

Top funds holding Autolus Therapeutics Plc spon ads

MAK Capital One
Blackstone Group
Syncona Portfolio
Armistice Capital
Polygon Management
Schroder Investment Management Group
Citadel Advisors
Renaissance Technologies
Frazier Life Sciences Management
BlackRock
AXA Investment Managers
Laurion Capital Management
Deep Track Capital
Acadian Asset Management
Affinity Asset Advisors

View all funds holding Autolus Therapeutics Plc spon ads